The Valley Desk

ArticleAlimentary pharmacology & therapeuticsPublished

Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, Philadelphia VA Medical Center, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Alimentary pharmacology & therapeutics
Published
Subject terms
Humans; Opportunistic Infections; Inflammatory Bowel Diseases; Retrospective Studies; Tumor Necrosis Factor Inhibitors; COVID-19; SARS-CoV-2; Inflammatory Bowel Disease; Veteran Affairs; Sars-cov-2
PubMed ID
36645110
PubMed Central ID
PMC10023400
Added to directory
Source checked

Report a correction or request removal